Cobimetinib-impurities | Pharmaffiliates

cobimetinib and its Impurities

It has been approved in Switzerland and the US, in combination with vemurafenib for the treatment of patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.. Reference standards of Cobimetinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 3 results for cobimetinib Impurities
PA 56 64000

Cobimetinib - API

Cobimetinib


  • Catalogue No.:PA 56 64000

  • CAS :

    934660-93-2

  • Molecular Formula : C21H21F3IN3O2

  • Molecular Weight : 531.31

PA STI 022391

Cobimetinib-d8

Cobimetinib-d8


  • Catalogue No.:PA STI 022391

  • CAS :

    NA

  • Molecular Formula : C21H13D8F3IN3O2

  • Molecular Weight : 539.37

PA 56 0641000

Cobimetinib (racemate)

Cobimetinib (racemate)


  • Catalogue No.:PA 56 0641000

  • CAS :

    934662-91-6

  • Molecular Formula : C21H21F3IN3O2

  • Molecular Weight : 531.32